Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis

Completed · Phase 1

Conditions studied: Atrophic Vaginitis

In brief

The purpose of this study is to characterize the systemic exposure and bioavailability at steady state of Premarin® Vaginal Cream compared with Premarin® oral tablets in postmenopausal women with atrophic vaginitis.

Key facts

Study ID

NCT00167921

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

24

Starts

2005-10-01

Last updated by the study team

2007-05-28

Who can join

Age: 45 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Generally healthy postmenopausal women.
• Intact uterus.
• Clinical diagnosis of moderate to severe atrophic vaginitis.

Where it is running

• Study site — Miami, Florida, United States
• Study site — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.